|
EXOSC6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.940400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.072400E-01 |
| Normal-vs-Stage2 |
1.779020E-01 |
| Normal-vs-Stage3 |
2.190200E-01 |
| Normal-vs-Stage4 |
4.037600E-01 |
| Stage1-vs-Stage2 |
3.375500E-02 |
| Stage1-vs-Stage3 |
2.500000E-01 |
| Stage1-vs-Stage4 |
5.057600E-01 |
| Stage2-vs-Stage3 |
1.720150E-02 |
| Stage2-vs-Stage4 |
4.860500E-02 |
| Stage3-vs-Stage4 |
8.650400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.765200E-01 |
| Normal-vs-AfricanAmerican |
4.370100E-02 |
| Normal-vs-Asian |
5.851600E-01 |
| Caucasian-vs-AfricanAmerican |
5.425800E-02 |
| Caucasian-vs-Asian |
2.218000E-01 |
| AfricanAmerican-vs-Asian |
1.418090E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.414760E-01 |
| Normal-vs-Female |
9.907600E-01 |
| Male-vs-Female |
2.668100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.096000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.926600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.211600E-01 |
| Normal-vs-Age(81-100Yrs) |
4.464400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.325190E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.260000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.628000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.031600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.749000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.386600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.344200E-02 |
| Classical-VS-Follicular |
8.066300E-02 |
| Classical-VS-Other |
5.160000E-03 |
| Classical-VS-Normal |
6.581000E-01 |
| Tall-VS-Follicular |
9.292000E-01 |
| Tall-VS-Other |
4.229800E-02 |
| Tall-VS-Normal |
2.420600E-01 |
| Follicular-VS-Other |
1.986580E-01 |
| Follicular-VS-Normal |
2.784400E-01 |
| Other-VS-Normal |
1.666130E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.614000E-01 |
| Normal-vs-N1 |
7.603200E-01 |
| N0-vs-N1 |
8.306000E-01 |
|
|
